Clinical Trials Sponsored by Laboratoires CARILENE

Total 2172 results

Forest Laboratories

Completed

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder (VLZ-MD-05)

Generalized Anxiety Disorder

United States
United Laboratories

Completed

Astaxanthin (2 mg) + Lycopene (1.8 mg) + D-Alpha-Tocopherol (10 IU) For The Treatment Of Skin Aging

Skin Aging | Wrinkles

Philippines
United Laboratories

Completed

Efficacy and Safety of Topical 0.5% Ivermectin Lotion for the Treatment of Head Lice Infestation in Filipinos

Pediculosis Capitis

Philippines
Forest Laboratories

Completed

A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States
Forest Laboratories

Completed

Diafert for Embryo Selection and Fertility Improvement (DESTINy) (DESTINy)

Infertility

Hungary
Forest Laboratories

Terminated

Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer

Neoplasms | Febrile Neutropenia

United States
Forest Laboratories

Completed

PR-018: An Open-Label, Safety Extension of Study PR-011

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Forest Laboratories

Completed

Efficacy and Safety of Ultrase® MT20 in Improving the Coefficient of Fat Absorption (CFA) in Children With Cystic Fibrosis (CF) and Pancreatic Insufficiency (PI)

Cystic Fibrosis | Pancreatic Insufficiency

United States
Forest Laboratories

Completed

Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Forest Laboratories

Completed

Safety and Efficacy Study of Viokase® 16 for the Correction of Steatorrhea

Chronic Pancreatitis | Exocrine Pancreatic Insufficiency | Pancreatectomy

Canada, United States, Poland, Slovakia
Forest Laboratories

Completed

Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)

Cystic Fibrosis | Pancreatic Insufficiency

United States
Forest Laboratories

Completed

Study to Evaluate the Safety and Efficacy of EUR-1008 (APT-1008) Pancreatic Enzyme Product in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Forest Laboratories

Completed

Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections

Bacterial Infection

United States
Winston Laboratories

Terminated

Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve

Postherpetic Neuralgia

United States
Forest Laboratories

Completed

Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)

Nausea

Canada
Forest Laboratories

Completed

Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)

Nausea

Canada
Forest Laboratories

Completed

Long-term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia

Dyspepsia
Forest Laboratories

Completed

Effect of Itopride, on Symptoms of Functional Dyspepsia, Such as Indigestion, Bloating, Inability to Finish a Meal

Dyspepsia

Canada
Forest Laboratories

Completed

Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering From Functional Dyspepsia

Dyspepsia
Forest Laboratories

Completed

Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

Congestive Heart Failure

United States
J.A.R. Laboratories

Unknown

Comparison of Prescription Lidocaine Patch to Over the Counter Lidocaine Patch and Placebo for Back Pain and Arthritis

Arthritis | Back Pain

United States
Forest Laboratories

Completed

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)

Infections | Pneumonia

United States, Ukraine, Argentina, Georgia
Forest Laboratories

Completed

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689)

Schizophrenia

United States
Forest Laboratories

Completed

An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

Autistic Disorder | Autism | Asperger's Disorder | Autism Spectrum Disorder (ASD) | Asperger's | Pediatric Autism | Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)

United States, Belgium, Colombia, Estonia, Hungary, Iceland, Italy, Korea, Republic of, New Zealand, Poland, Serbia, South Africa, Spain, Ukraine, Australia, Canada, France, Singapore
Artann Laboratories

Completed

Study With Advanced Vaginal Tactile Imager

Investigative Techniques

United States
Forest Laboratories

Completed

Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

Germany, Poland
Forest Laboratories

Completed

Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder

Major Depressive Disorder

United States
Braintree Laboratories

Completed

BLI850-302: BLI850 vs an Approved Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Colon Cancer

United States
Neogenis Laboratories

Unknown

Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults

Prehypertension

United States
Materna Laboratories

Unknown

Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.

Focus on Healthy Infant Growth.

Israel
Prometheus Laboratories

Completed

LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) (RELIANCE)

Irritable Bowel Syndrome

United States
Braintree Laboratories

Completed

Comparison of PolyethyleneGlycol and Placebo for Relief of Constipation From Constipating Medications

Constipation

United States
Braintree Laboratories

Completed

Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients

Constipation

United States
Braintree Laboratories

Completed

PolyethyleneGlycol3350 Laxative vs Placebo in Constipated Children

Constipation

United States
Braintree Laboratories

Completed

BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Forest Laboratories

Completed

Study of Oglemilast for the Prevention of Asthma.

Exercise-Induced Asthma

United States
Forest Laboratories

Completed

Study of Oglemilast for the Treatment of Asthma

Asthma

United States
Forest Laboratories

Completed

Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients

Schizophrenia

United States
Forest Laboratories

Completed

Study of Escitalopram in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder

Bipolar Disorder

United States
Forest Laboratories

Completed

Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories

Completed

Efficacy and Safety Evaluation of Azimilide Dihydrochloride in Patients With Implantable Cardioverter Defibrillators

Arrhythmia

United States, Canada, Germany, Belgium, France, Italy, Netherlands, Poland, Spain
Rafa Laboratories

Terminated

Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression

Depression

Israel
Winston Laboratories

Completed

Evaluating the Safety and Efficacy Civamide in Osteoarthritis (OA) of the Knee(s)

Osteoarthritis of the Knee
Forest Laboratories

Completed

A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients

Hypertension

United States, Puerto Rico
Braintree Laboratories

Completed

F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

Colonoscopy

United States
Prometheus Laboratories

Completed

Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis

Colitis, Ulcerative

United States
Forest Laboratories

Completed

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

Coronary Artery Disease | Hypertension

United States
Forest Laboratories

Completed

A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients

Hypertension

United States
Forest Laboratories

Completed

Study Evaluating RGH-188 in the Treatment of Patients With Schizophrenia

Schizophrenia

United States

3

Subscribe